Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Innodata INOD provides Generative AI GenAI-focused services through its Digital Data Solutions segment, which contributed 87% of total revenues in the first quarter of 2025. INOD supports leading ...

Validation-scientist-turned-data architect Lalitha Amarapalli is one of the few who do. Across sixteen years she has drafted ...

This precision medicine approach, driven by granular, real-world evidence, is critical for reshaping clinical guidelines and ...

As countries begin to establish AI regulations, engineers designing AI-enabled systems must meet newly introduced ...

The Model Context Protocol (MCP) provides a modern, semantically rich way for AI to interact with enterprise systems.

Let’s start with a truth that too many people still overlook — not all data is good data. Just because something is sitting in a database or spreadsheet doesn’t mean it’s accurate, trustworthy, or ...

Mild cognitive impairment (MCI) and dementia pose significant health challenges in aging societies, emphasizing the need for accessible, cost-effective, and noninvasive diagnostic tools.

F5 and MinIO announced an expanded strategic partnership to deliver high-performance, secure, and scalable data pipelines for ...

In this episode of Today in Tech, host Keith Shaw speaks with Marc Prioleau, executive director of the Overture Maps ...

Peering out a window at Torslanda Works, one of Volvo's largest production facilities in Sweden, reveals a side lot filled ...